Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2022), Lancet, 399, 143 - 151
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), The Lancet. Respiratory medicine, 9, 1419 - 1426
Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort
Journal article
Keng MJ. et al, (2021), Value in Health
What is the association of COVID-19 with heart attacks and strokes?
Other
Mafham M. and Baigent C., (2021), Lancet, 398, 561 - 563
The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19.
Journal article
Pessoa-Amorim G. and Mafham MM., (2021), Cardiovasc Res, 117, e110 - e113
Making trials part of good clinical care: lessons from the RECOVERY trial.
Journal article
Pessoa-Amorim G. et al, (2021), Future Healthc J, 8, e243 - e250
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
RECOVERY Collaborative Group None. et al, (2021)
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
RECOVERY Collaborative Group None. et al, (2021)
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Working paper
RECOVERY Collaborative Group None., (2021), Lancet, 397, 2049 - 2059
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet, 397, 1637 - 1645
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
The RECOVERY Collaborative Group None. et al, (2021)
A biomarker-based biological age in UK Biobank: composition and prediction of mortality and hospital admissions.
Journal article
Chan MS. et al, (2021), J Gerontol A Biol Sci Med Sci
Dexamethasone in Hospitalized Patients with Covid-19.
Journal article
RECOVERY Collaborative Group None. et al, (2021), N Engl J Med, 384, 693 - 704
Place and Underlying Cause of Death During the COVID-19 Pandemic: Retrospective Cohort Study of 3.5 Million Deaths in England and Wales, 2014 to 2020.
Journal article
Wu J. et al, (2021), Mayo Clin Proc
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet, 397, 605 - 612
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet, 397, 605 - 612
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial
Working paper
RECOVERY Collaborative Group None. et al, (2021)
Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
Horby P. et al, (2020)
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
Journal article
RECOVERY Collaborative Group None. et al, (2020), N Engl J Med, 383, 2030 - 2040
Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial
Conference paper
Rocca B. et al, (2020), EUROPEAN HEART JOURNAL, 41, 2926 - 2926